NQVAX vs. FASEX

Last updated Jun 4, 2026

NQVAX (Nuveen Multi-Cap Value Fund Class A) and FASEX (Nuveen Mid Cap Value Fund) are both mutual funds - NQVAX is a Large Cap Value Equities fund actively managed by Nuveen, while FASEX is a Mid Cap Value Equities fund managed by Nuveen. Over the past 10 years, NQVAX returned 12.66%/yr vs 10.97%/yr for FASEX. Their correlation of 0.93 suggests significant overlap in exposure. NQVAX charges 1.15%/yr vs 1.16%/yr for FASEX.

Performance

NQVAX vs. FASEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nuveen Multi-Cap Value Fund Class A (NQVAX) and Nuveen Mid Cap Value Fund (FASEX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NQVAX achieves a 13.25% return, which is significantly lower than FASEX's 17.58% return. Over the past 10 years, NQVAX has outperformed FASEX with an annualized return of 12.66%, while FASEX has yielded a comparatively lower 10.97% annualized return.

NQVAX

• 1D: 0.44%
• 1M: 1.61%
• YTD: 13.25%
• 6M: 14.26%
• 1Y: 31.93%
• 3Y*: 19.97%
• 5Y*: 12.57%
• 10Y*: 12.66%

FASEX

• 1D: 1.68%
• 1M: 3.56%
• YTD: 17.58%
• 6M: 17.64%
• 1Y: 30.46%
• 3Y*: 16.66%
• 5Y*: 9.31%
• 10Y*: 10.97%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NQVAX vs. FASEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NQVAX Nuveen Multi-Cap Value Fund Class A	13.25%	17.62%	18.95%	15.65%	-1.27%	28.22%	-0.51%	29.99%	-14.58%	18.37%
FASEX Nuveen Mid Cap Value Fund	17.58%	9.68%	10.40%	14.20%	-10.63%	34.84%	1.19%	26.68%	-13.00%	19.23%

Correlation

The correlation between NQVAX and FASEX is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.90
Correlation (3Y) Calculated over the trailing 3-year period	0.93
Correlation (5Y) Calculated over the trailing 5-year period	0.94
Correlation (10Y) Calculated over the trailing 10-year period	0.93
Correlation (All Time) Calculated using the full available price history since Dec 9, 2002	0.93

The correlation between NQVAX and FASEX has been stable across timeframes, ranging from 0.90 to 0.94 - a consistent structural relationship.

Return for Risk

NQVAX vs. FASEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NQVAX

NQVAX Risk / Return Rank: 78
NQVAX Sharpe Ratio Rank: 77
NQVAX Sortino Ratio Rank: 72
NQVAX Omega Ratio Rank: 64
NQVAX Calmar Ratio Rank: 89
NQVAX Martin Ratio Rank: 88

FASEX

FASEX Risk / Return Rank: 70
FASEX Sharpe Ratio Rank: 63
FASEX Sortino Ratio Rank: 62
FASEX Omega Ratio Rank: 53
FASEX Calmar Ratio Rank: 88
FASEX Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NQVAX vs. FASEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nuveen Multi-Cap Value Fund Class A (NQVAX) and Nuveen Mid Cap Value Fund (FASEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NQVAX	FASEX	Difference
Sharpe ratio: Return per unit of total volatility	2.55	2.33	+0.22
Sortino ratio: Return per unit of downside risk	3.54	3.30	+0.24
Omega ratio: Gain probability vs. loss probability	1.45	1.40	+0.04
Calmar ratio: Return relative to maximum drawdown	4.48	4.35	+0.13
Martin ratio: Return relative to average drawdown	17.15	15.87	+1.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NQVAX vs. FASEX - Sharpe Ratio Comparison

The current NQVAX Sharpe Ratio is 2.55, which is comparable to the FASEX Sharpe Ratio of 2.33. The chart below compares the historical Sharpe Ratios of NQVAX and FASEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NQVAX	FASEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.55	2.33	+0.22
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.78	0.52	+0.26
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.67	0.54	+0.12
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.52	-0.07

Drawdowns

NQVAX vs. FASEX - Drawdown Comparison

The maximum NQVAX drawdown since its inception was -67.90%, which is greater than FASEX's maximum drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for NQVAX and FASEX.

Drawdown Indicators

	NQVAX	FASEX	Difference
Max Drawdown Largest peak-to-trough decline	-67.90%	-55.57%	-12.33%
Max Drawdown (1Y) Largest decline over 1 year	-7.41%	-7.37%	-0.04%
Max Drawdown (3Y) Largest decline over 3 years	-18.01%	-22.26%	+4.25%
Max Drawdown (5Y) Largest decline over 5 years	-18.01%	-22.26%	+4.25%
Max Drawdown (10Y) Largest decline over 10 years	-42.29%	-44.56%	+2.27%
Current Drawdown Current decline from peak	-1.22%	0.00%	-1.22%
Average Drawdown Average peak-to-trough decline	-11.81%	-8.93%	-2.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.93%	2.01%	-0.08%

Volatility

NQVAX vs. FASEX - Volatility Comparison

Nuveen Multi-Cap Value Fund Class A (NQVAX) and Nuveen Mid Cap Value Fund (FASEX) have volatilities of 4.36% and 4.26%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NQVAX	FASEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.36%	4.26%	+0.10%
Volatility (6M) Calculated over the trailing 6-month period	9.85%	10.24%	-0.39%
Volatility (1Y) Calculated over the trailing 1-year period	13.00%	13.76%	-0.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.25%	18.07%	-1.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.11%	20.21%	-1.10%

NQVAX vs. FASEX - Expense Ratio Comparison

NQVAX has a 1.15% expense ratio, which is lower than FASEX's 1.16% expense ratio.

Dividends

NQVAX vs. FASEX - Dividend Comparison

NQVAX's dividend yield for the trailing twelve months is around 1.46%, less than FASEX's 12.48% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FASEX Nuveen Mid Cap Value Fund	12.48%	14.67%	5.29%	3.12%	6.32%	4.02%	1.06%	0.89%	4.48%	7.93%	3.67%	3.49%
NQVAX Nuveen Multi-Cap Value Fund Class A	1.46%	1.66%	1.62%	1.06%	1.17%	1.23%	3.17%	1.10%	0.00%	1.76%	0.79%	0.78%

Frequently Asked Questions

Can I hold both NQVAX and FASEX in my portfolio?

With a correlation of 0.90, NQVAX and FASEX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, NQVAX or FASEX?

NQVAX has higher volatility (4.36%) compared to FASEX (4.26%). In terms of maximum drawdown, NQVAX dropped -67.90% vs FASEX's -55.57%.

Which has better risk-adjusted returns?

NQVAX currently has the higher Sharpe Ratio (2.55 vs 2.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.